Skip to main content
. Author manuscript; available in PMC: 2017 Oct 30.
Published in final edited form as: Depress Anxiety. 2016 May 10;33(9):870–881. doi: 10.1002/da.22521

Table 2.

Means (standard deviations) for changes from baseline to follow-up for measures of physical and social functioning across both exercise groups

Measure 4-KKW Group Effect Sizea p N (%) in Healthy Range 16-KKW Group Effect Sizea p N (%) in Healthy Range p (btwn groups)
SF-36 Physical Functioning
 Baseline 79.4 (20.9) 51 (89.5) 79.5 (19.5) 41 (85.4)
 Week 6 82.5 (19.2) 0.15 0.250 51 (92.7) 87.8 (13.8) 0.54 <0.001* 45 (100.0) 0.052
 Week 12 85.0 (19.2) 0.37 0.007 45 (91.8) 85.3 (18.7) 0.38 0.011 40 (88.9) 0.993
SF-36 Role- Physical
 Baseline 74.8 (29.7) 41 (78.9) 74.6 (28.0) 35 (79.6)
 Week 6 75.2 (26.4) 0.03 0.829 47 (87.0) 82.7 (17.8) 0.33 0.029 41 (95.4) 0.077
 Week 12 79.7 (24.8) 0.17 0.230 41 (87.2) 81.5 (20.0) 0.23 0.120 41 (95.4) 0.759
SF-36 Bodily Pain
 Baseline 67.0 (24.2) 53 (91.4) 72.2 (18.5) 46 (95.8)
 Week 6 71.6 (23.5) 0.07 0.579 51 (91.1) 70.6 (20.5) 0.01 0.957 42 (93.3) 0.683
 Week 12 72.3 (24.5) 0.16 0.259 43 (87.8) 72.6 (21.1) 0.08 0.606 42 (93.3) 0.683
SF-36 General Health
 Baseline 60.8 (20.6) 45 (77.6) 59.2 (20.1) 36 (75.0)
 Week 6 67.3 (18.5) 0.45 0.001* 49 (87.5) 66.8 (18.9) 0.51 0.001* 40 (88.9) 0.768
 Week 12 69.5 (18.5) 0.57 <0.001* 43 (89.6) 66.8 (19.7) 0.54 <0.001* 36 (81.8) 0.852
SF-36 Vitality
 Baseline 28.2 (19.7) 22 (37.9) 27.2 (17.3) 15 (31.3)
 Week 6 39.8 (21.3) 0.55 <0.001* 33 (60.0) 39.2 (17.9) 0.59 <0.001* 27 (60.0) 0.830
 Week 12 44.1 (24.4) 0.83 <0.001* 31 (63.3) 43.5 (21.2) 0.79 <0.001* 31 (68.9) 0.823
SF-36 Social Functioning
 Baseline 49.4 (28.2) 24 (41.4) 57.6 (23.6) 25 (52.1)
 Week 6 58.7 (28.8) 0.33 0.014 34 (60.7) 66.1 (21.9) 0.52 0.001* 30 (66.7) 0.327
 Week 12 64.8 (26.0) 0.64 <0.001* 32 (65.3) 76.4 (21.8) 0.95 <0.001* 36 (81.8) 0.116
SF-36 Role- Emotional
 Baseline 47.3 (26.1) 18 (31.0) 50.3 (26.5) 16 (33.3)
 Week 6 63.4 (31.6) 0.61 <0.001* 31 (55.4) 64.4 (26.0) 0.61 <0.001* 21 (46.7) 0.993
 Week 12 70.1 (26.4) 0.91 <0.001* 33 (67.4) 70.2 (25.3) 0.83 <0.001* 30 (66.7) 0.673
SF-36 Mental Health
 Baseline 49.1 (15.9) 27 (46.6) 50.7 (13.9) 20 (41.7)
 Week 6 58.6 (18.0) 0.52 <0.001* 35 (62.5) 61.5 (17.8) 0.62 <0.001* 30 (66.7) 0.594
 Week 12 62.4 (21.0) 0.80 <0.001* 34 (69.4) 67.2 (18.5) 0.95 <0.001* 33 (73.3) 0.460
SAS-SR
 Baseline 2.4 (0.4) 11 (19.0) 2.5 (0.4) 3 (6.3)
 Week 6 2.3 (0.4) 0.38 0.004* 16 (28.6) 2.2 (0.4) 0.80 <0.001* 18 (40.0) 0.035
 Week 12 2.1 (0.5) 0.99 <0.001* 24 (49.0) 2.1 (0.4) 0.93 <0.001* 20 (44.4) 0.804
WSAS
 Baseline 20.8 (9.9) 3 (5.2) 18.7 (7.1) 2 (4.2)
 Week 6 16.8 (9.7) 0.43 0.001* 5 (9.1) 15.8 (9.2) 0.42 0.006* 5 (11.1) 0.957
 Week 12 14.6 (10.8) 0.75 <0.001* 9 (18.0) 12.0 (9.8) 0.81 <0.001* 12 (26.7) 0.726

Note:

a

Effect sizes follow the convention for Cohen's d and measure the strength of the covariate-adjusted mean change between each time point and baseline;

*

significant change from baseline after applying Bonferroni correction. No significant between-group differences were found.